▲ 0.80%
prev close
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Congressional Trades
5
All tracked trades
Members Trading
3
Unique members
Net Activity
-3
1 buys · 4 sells
Members Who Traded This Stock
5 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-09-11 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 273d ago | — | |
| 2025-08-04 | SNYSanofi - American Depositary Shares | Buy | $1,001 - $15,000 | 313d ago | — | |
| 2025-07-22 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 343d ago | — | |
| 2024-09-04 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 684d ago | — | |
| 2022-03-16 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 1555d ago | — |
2025-09-11
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
273d ago
2025-08-04
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
313d ago
2025-07-22
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
343d ago
2024-09-04
John James
SNY
Amount
$1,001 - $15,000
Filed
684d ago
2022-03-16
John Rutherford
SNY
Amount
$1,001 - $15,000
Filed
1555d ago
Recent News
Powered by Polygon.io
Antiparasitic Drugs Market Report Released — Examines Antimalarials, Anthelmintics, Antiprotozoals, Ectoparasiticides, and Neglected Tropical Disease Therapies
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
Dupilumab Achieves Record $11.9 Billion in Global Sales Amidst Continued Growth
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-09-11 · Sale
$1,001 - $15,000
Lisa McClain
2025-08-04 · Purchase
$1,001 - $15,000
Lisa McClain
2025-07-22 · Sale
$1,001 - $15,000
John James
2024-09-04 · Sale
$1,001 - $15,000
John Rutherford
2022-03-16 · Sale
$1,001 - $15,000